Note 5 - Net (Loss) Income Per Share

6 Months Ended

Jun. 30, 2022

Notes to Financial Statements

Earnings Per Share [Text Block]

5. Net (Loss) Income Per Share

Basic net (loss) income per share is computed using the weighted average number of common shares outstanding during the three-and-six-month ended June 30, 2022, and 2021, excluding any unvested restricted stock. Diluted net (loss) income per share is computed using the weighted average number of common shares, and if dilutive, potential common shares outstanding, as determined under the treasury stock and if-converted methods, during the three-and-six-month ended June 30, 2022, and 2021. Potential common shares consist of unvested restricted stock, common shares issuable upon the exercise of stock options and the exercise of warrants.

The following are the share amounts utilized to compute the basic and diluted net (loss) income per share for the three and six months ended June 30, 2022, and 2021:

	Three Months Ended June 30,						Six Months Ended June 30,
	2022			2021			2022			2021
Basic Shares:
Weighted average common shares outstanding		14,051,149			13,461,044			13,947,779			13,357,622
Weighted average unvested restricted stock		(708,334	)		(220,000	)		(628,840	)		(148,370	)
Basic Shares		13,342,815			13,241,044			13,318,939			13,209,252
Diluted Shares:
Basic shares		13,342,815			13,241,044			13,318,939			13,209,252
Weighted average dilutive securities		—			—			—			204,543
Diluted Shares		13,342,815			13,241,044			13,318,939			13,413,795

For the three and six months ended June 30, 2022, and the three months ended June 30, 2021, the Company’s basic and diluted net loss per share are the same because the Company generated a net loss for the period and potentially dilutive securities are excluded from diluted net loss per share because they have an anti-dilutive impact.

For the six months ended June 30, 2021, weighted average dilutive securities include dilutive options and restricted stock awards.

For the three and six months ended June 30, 2022, the Company had 13,932 and 31,823, respectively, of potentially anti-dilutive securities related to common stock that have been excluded from the calculation of diluted net earnings per share. For the three and six months ended June 30, 2021, the Company had 4.6 million and 4.5 million of potentially anti-dilutive securities related to common stock that have been excluded from the calculation of diluted net earnings per share.